CAPA news
With These Hands
Arthritis has inspired artwork by fibre artist, Karen D. Miller. She developed “With these hands” to convey the ability – not the disability – of CAPA Board member Laurie Proulx. Read a few words from the artist about what this piece means to her. “This is a piece that I originally finished in 2015, but over the [&hell
CAPA, Arthritis Society and Cassie & Friends CADTH Submission on Anakinra (Kineret) for Still’s and SJIA
In preparation for the CADTH submission for a manufacturer’s drug Anakinra (Kineret) for the treatment of Still’s disease in children and adults, the Canadian Arthritis Patient Alliance in collaboration with the Arthritis Society and Cassie and Friends developed a survey to hear directly from people living with Still’s disease and SJIA ab
CAPA Letter on NACI’s Recommendations on Approved COVID-19 Vaccines for People with Autoimmune Disease
The National Advisory Committee on Immunization’s (NACI’s) issued recommendations on the currently approved COVID-19 vaccines. As individuals who live with autoimmune disease and who are on immunosuppressant therapies, we ask that Committee to consider our perspectives and preferences in NACI's continued updates to the recommendations and as
What is Health Technology Assessment?
Are you wondering what is health technology assessment? Who is responsible for health technology assessment and how do health technology assessment organizations make their decisions? Learn more about it here.
Call for Patient Input on Anakinra for Still’s disease and SJIA Submission
Do you or a family member have Still’s disease or Systemic Idiopathic Juvenile Arthritis (SJIA)? If so, your valuable input is needed to the Common Drug Review (CDR) on the manufacturer’s submission for Anakinra (Kineret) for the treatment of Still’s disease and SJIA in adults and pediatric patients aged 8 months and older!
Your Input Needed to Submission for Upadacitinib for the treatment of PsA
The Common Drug Review (CDR) is welcoming patients to provide input to patient organizations on the manufacturer’s submission for upadacitinib for the treatment of psoriatic arthritis (PsA). Please be one of the first respondents to this survey available in English and French!
Meet CAPA Board member – Therese Lane
“I like living in a solution instead of a problem”. We invite you to listen to CAPA's one of the new Board members, Therese Lane's compelling story of living with arthritis and what made her become the patient advocate!
The Canadian Pain Taskforce on the Pain Waves podcast
Learn about the Canadian Pain Taskforce's latest work, what they heard from Canadians during their consultations, about the expected impact of their latest report to government and next steps for the Taskforce’s three-year mandate.
CAPA newsletters
Newsletter – December 2020
2020 has been a challenging year for so many of us! As CAPA team, we have tried our best to support the arthritis community throughout the pandemic by addressing drug shortages, developing evidence-based resources, hosting a virtual fashion show and many more. To end the year on a lighter note, the CAPA Board of Directors wish you the best holiday season and best of luck in the year ahead!
Newsletter – November 2020
This month CAPA has introduced its #ArthritisThenNow infographic designed to describe how arthritis treatments and life has changed for people living with inflammatory arthritis over the last 20 years! Read more about many other activities and projects we have been involved into!
Newsletter – October 2020
This month CAPA has teamed up with CreakyJoints in the United States and Australia to bring our readers special content devoted to the World Arthritis Day for them to learn what it’s like to live with arthritis during the pandemic from a global perspective.
Newsletter – September 2020
In this newsletter edition, we are celebrating the September Arthritis Awareness Month and presenting our new video with Board member and fashion designer, Michael Kuluva, as he speaks with 2nd VP, Laurie Proulx and...much more in this edition. Join us in raising awareness about arthritis!
Newsletter – Summer 2020
This newsletter edition highlights CAPA's activities during the summer season. We kept on contributing patient perspectives to research, health policy and education. Read our summer newsletter to find out more.
Newsletter – June 2020
This month CAPA team have been actively participated in various initiatives while pandemic is moving into a new stage. CAPA's #ArthritisAtWork social media campaign video presentation was the highlight of the international EULAR e-Congress held on June 6, 2020. Read more about what we have been up to!
Newsletter – May 2020
There have been difficult few months for people living with arthritis, so this month we tried to highlight the 'lighter side' of the pandemic and bring laughs and smiles through conversation and chats on Twitter.
Newsletter – April 2020
This month we have been regularly updating the COVID-19 web page on our website with new information, including changes to public drug plans and new links to reliable information.
When you live with arthritis,
information is your most important tool.
The Canadian Arthritis Patient Alliance (CAPA) works with various groups in the arthiritis community to ensure the voice of people living with arthritis is heard and to bring you up-to-date information on issues that affect the arthritis community. We work with healthcare professionals, health organizations, clinicians, industry, health charities, researchers, and various levels of government.
We keep Canadian people living with arthritis and their support groups understand more about their disease and have a voice in managing it.